Phase-II clinical trial of 4′-epi-doxorubicin in metastatic solid tumors
- 1 October 1983
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 106 (2) , 148-152
- https://doi.org/10.1007/bf00395394
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Toxic and Therapeutic Activity of 4'-Epi-DoxorubicinTumori Journal, 1982
- EFFECT OF 4'-DOXORUBICIN ANALOGS ON HETERO-TRANSPLANTATION OF HUMAN-TUMORS IN CONGENITALLY ATHYMIC MICE1981
- A PHASE-I TRIAL OF 4'-EPI-ADRIAMYCIN1981
- UICC Conference on Clinical Oncology, Lausanne, Switzerland, 29–31 October 1981Leukemia Research, 1980
- STUDIES ON THE COMPARATIVE DISTRIBUTION AND BILIARY-EXCRETION OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN MICE AND RATS1980
- Experimental evaluation of anthracycline analogs.1979
- Preliminary phase I study of 4'-epi-adriamycin.1979
- Modified administration schedule of Adriamycin in solid tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975